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Abstract
The Chapter contains information about the prevalence of heart failure (HF) 
among patients in outpatient practice. The causal structure of HF, the prevalence of 
risk factors for HF, and the occurrence of a reduced ejection fraction are described. 
It describes the frequency of overdiagnosis of HF, the disease most often simulating 
its symptoms. The difficulties associated with laboratory and instrumental diagnos-
tics of this syndrome are discussed. A pharmacological test for differential diagno-
sis of the causes of dyspnea in patients with suspected HF is described. Information 
is provided on the incidence of depressive and anxiety among the patients with this 
disease.
Keywords: heart failure, prevalence, outpatient, diagnostics, differential diagnostics, 
pharmacological test, torasemide, depressive, anxiety
1. Introduction
Chronic HF is a common complication of cardiovascular diseases. The wide-
spread prevalence of this pathology in the world in recent years has taken on the 
scale of an epidemic. Tens of millions of people around the world suffer from this 
disease. It can be made with the growing burden of obesity-related diseases and 
with the aging of the population [1]. Probably, it is also important to increase the 
survival rate after acute forms of coronary artery disease and increase the life 
expectancy of patients with HF. Diagnosis of chronic HF is a major clinical prob-
lem, especially in patients with comorbidities [2]. This Chapter aims to highlight the 
features of the diagnosis of HF in an outpatient setting.
2. The prevalence of heart failure among patients in outpatient practice
The reasons for visiting a polyclinic by patients are often acute diseases, the need 
for a health examination, or dispensary monitoring for chronic diseases. The cohort 
of such visitors does not accurately reflect the state of the population, but these are 
the people that outpatient doctors have to deal with.
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Many variants of criteria for the diagnosis of heart failure in epidemiological 
studies have been developed. Their diversity highlights the inferiority of diagnostic 
methods. There are Framingham, Gothenburg, Boston, European society of cardi-
ology criteria and others. We used a questionnaire proposed by the Russian society 
of heart failure specialists [3]. The questionnaire includes a question about the 
presence of shortness of breath, confirmation of myocardial damage by instrumen-
tal methods, taking diuretics, a known diagnosis of heart failure, and a decrease in 
the left ventricular ejection fraction of less than 50%. A positive answer to the first 
question and any subsequent question makes it likely that the patient has HF.
In a survey of 3,000 adults who consecutively applied to the outpatient clinic, 
it was found that 543 patients were suspected of heart failure. The recruitment 
of people in the study was carried out by age and gender groups identical to the 
population living in the city. Among people who visit an outpatient department, 
the clinical suspicion of heart failure among men is 12.3%, among women it reaches 
22.9% [4]. At the same time, it is possible to confirm the presence of heart failure in 
11.7% of outpatient patients. In 36.2% of outpatient visitors with suspected HF, the 
disease is not confirmed during further examination. These cases were 57% more 
common among women compared to men.
The specificity of the questionnaire used was 63.8%. Thus, after clinical screen-
ing for possible HF, additional methods should be used that exclude the situation of 
overdiagnosis.
The vast majority of patients (87%) have HF with preserved ejection fraction 
(EF). However, among hospitalized patients with heart failure, the ratio between 
preserved and reduced ejection fraction is approximately one to one [5].
3.  The prevalence of risk factors of heart failure among patients  
in outpatient practice
An analysis of a sample of 3,000 outpatient visitors found that the prevalence 
of obesity among adult outpatient patients is 20% (95% CI: 18.6–21.4%). Obesity 
increased the likelihood of shortness of breath in men and women almost equally 
(the relative risk was 2.39 and 2.49, respectively). The prevalence of diabetes mel-
litus, according to the survey, among adult outpatient visitors is 5.9%. The preva-
lence of smoking and alcohol abuse among adult outpatient visitors is 35% and 
12.4%, respectively. The prevalence of MI among adult outpatient patients is 4.7%. 
According to the survey, the prevalence of hypertension among adult outpatient 
visitors was 37.9%.
Hence, among the risk factors, arterial hypertension has the greatest population 
contribution to the development of HF. It was found that not only the presence 
and severity of arterial hypertension affected the development of HF, but also the 
duration of increased blood pressure. Thus, in patients with confirmed HF, dyspnea 
developed on average only 8.4 years after the onset of hypertension, and in patients 
with excluded HF, dyspnea occurred only 2.8 years later. That is, when assessing 
the probability of a connection between the appearance of shortness of breath, the 
exposure to hypertension should be taken into account.
4. The clinical diagnosis of heart failure
The diagnosis of chronic HF begins, of course, with the patient’s complaints. 
Thanks to the existing complaints of the patient that he comes into our field of 
vision. However, the complaints are not specific. If the patient has a complex of 
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manifestations of heart failure such as oedema, orthopnea, complaints of dyspnea, 
heaviness in the right hypochondrium, fatigue, then we will not be difficult to 
diagnose HF. But if we consider each of the signs of heart failure separately, it turns 
out that their specificity is quite low. And just such a situation is observed in the 
initial manifestations of heart failure. These patients, who have 1–2 manifestations, 
are the cornerstone of the diagnosis of initial forms of heart failure.
The most common manifestation of chronic heart failure is a complaint of 
shortness of breath. The sensitivity of this sign is close to 100%, but the specificity 
is only 17% [6]. When dyspnea is difficult for the patient to inhale, it has mostly 
inspiratory character. The shortness of breath is quite stereotypical. It cannot be 
there for a while, then disappear and reappear spontaneously. Without a treat-
ment it constantly progresses as a rule. In patients with limited mobility, dyspnea 
may not appear during exercise, but may debut at night in a horizontal position. 
Short-acting nitrates and diuretics can have a good effect on dyspnea of cardiac 
origin. The dyspnea increases as the intensity of the cause increases. For example, 
an increase of blood pressure or the appearance of paroxysms of atrial fibrillation 
or onset of angina pectoris usually cause an increase in dyspnea. When shortness 
of breath increases, a cough is added, first dry, then with foamy sputum and blood. 
This may occur during a period of inadequate physical activity of the patient. If 
shortness of breath manifests at rest, then there is more accurate sign of heart 
failure: shortness of breath becomes heavier in a horizontal position and is relieved 
when the head end of the trunk is raised. The patient’s forced sitting position is 
called orthopnea. The analysis of these features of dyspnea allows for more accurate 
diagnosis of heart failure.
Bendopnea, described in recent years [7], is the occurrence of shortness of 
breath after bending the patient sitting in a chair and pressing the abdominal belt. 
Shortness of breath in a patient with CHF persists for at least 30 seconds. However, 
this sign is not specific enough and can be observed in lung diseases and obesity [8].
Another sign of heart failure is rapid fatigue during physical activity and longer 
recovery after exercise. Fatigue is observed in about 85% of patients with HF [9]. The 
appearance of this symptom is associated with a violation of nutrition and structural 
adjustment of muscle tissue in patients, but may be due to hypovolemia and hypoka-
lemia due to the use of diuretics. The specificity of the sign is extremely low, but good 
performance quite accurately indicates the absence of heart failure in the patient. 
Weakness in heart failure cannot be reduced by short-term training. In the initial 
stages of the disease, the patient does not feel weak at rest. It occurs only during 
physical activity. The patient is able to withstand short-term quite intense physi-
cal activity and at the same time gets very tired with low-intensity, but prolonged 
exercise. But even with these features, fatigue is a low-specific sign of heart failure.
The appearance of heaviness in the right hypochondrium indicates an increase 
in the liver due to stagnation in the large circle of blood circulation. The widespread 
pathology of the gallbladder makes this clinical sign very non-specific.
Oedema in patients with heart failure starts from the lower part of the legs 
and gradually involves the upper parts. In bedridden patients, edema forms on 
the sacrum. Oedema has a dense consistency. Their prolonged existence leads to 
hyperpigmentation of the skin and trophic changes in the area of oedema.
The patient’s complaints must be coordinated with the physical examination 
data. Low exercise tolerance should correlate with the appearance of signs of con-
gestion. The process of congestion, as a rule, from the beginning involves a small 
circle of blood, and for a long time during auscultation of the lungs we do not find 
wheezing. As a rule, wheezing in the lungs appears when the patient has shortness 
of breath at rest or with minimal physical activity. With long-term heart failure, 
a patient with wheezing lungs may not have shortness of breath at rest. Wheezing 
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appears from the lower parts of the lungs. They are moist, small-bubbly, in the 
beginning not sound, but with the appearance of fibrosis of the lungs they become 
resounding and do not respond to treatment with diuretics.
The formation of congestion in a large circle of blood circulation is manifested 
by an increase and soreness of the liver. When pressing on the liver during deep 
breathing of the patient, you can see an increase in blood filling of the neck veins 
by >3 cm sustained during 10 s (hepatojugular reflux), with an abrupt fall after 
the pressure is released [10]. This proves the connection between an enlarged liver 
and increased pressure in the veins of the large circle of blood. The appearance of 
tricuspid insufficiency is accompanied by the occurrence of pulsation of the neck 
veins. Due to the decline in the contractility of the right ventricle, the patient has a 
decrease in shortness of breath, but an increase in weakness.
Oedema of the lower extremities sometimes precedes the appearance of hepato-
megaly, but it also happens the other way around. This depends only on the innate 
predisposition to leg swelling and also from the patient’s position. Oedema is dense 
in consistency, appearing first in the lower areas, then rising to the top. With long-
term oedema in the area of their localization, skin atrophy occurs, hyperpigmenta-
tion appears, and the skin becomes easily vulnerable.
The third heart tone occurs when the pressure of filling the left ventricle in the 
diastole is increased. Listening to the third heart tone is specific for heart failure, 
but it is extremely rare among outpatients.
If there is a suspicion of heart failure in the patient, you need to go upstream. In 
other words, it is necessary to determine the probability of developing heart failure in 
the patient. When communicating with the patient, you need to pay attention to the 
coincidence of manifestations of heart disease and possible manifestations of heart 
failure. In addition, it is important to determine the dependence of manifestations on 
heart disease. Frequent provocateurs of heart failure are uncontrolled arterial hyper-
tension, paroxysms of fibrillation or atrial flutter, the development of acute coronary 
syndrome, alcohol abuse, sodium or fluid overload and the addition of infection.
To sum up, it should be noted that the accuracy of the diagnosis of HF based on 
clinical manifestations and physical examination data depends on the number of 
detected signs and symptoms, as well as on the chronological relationship with the 
cause of occurrence. Data analysis requires the use of clinical thinking.
5. Issues of differential diagnosis of signs and symptoms of HF
To begin differential diagnosis of manifestations similar to SN, you should 
always ask whether there is a reason for its development and whether the patient 
has a disease that can explain the manifestations. For example, if a patient has 
atrial fibrillation, the occurrence of shortness of breath after the development of a 
rhythm disorder should be explained by heart failure. And if a patient without heart 
disease has anemia, then shortness of breath is probably due to this cause.
But it is not necessary for a patient with heart disease to have shortness of breath 
only of cardiac origin. It should be mentioned once again that in every third case 
among outpatient visitors, who had a cardiovascular disease, HF is falsely diag-
nosed. And among women, this is 2 times more common than among men.
We found that most of the patients with cardiovascular disease and misdiag-
nosed heart failure suffer from anxiety disorders (53%). Second place is taken by 
obesity (39%). Then among the causes are decrepitude, pathologies of the respira-
tory system and anemia. There is no doubt that the patient may have different 
causes of symptoms.
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For example, a patient with arterial hypertension and obesity may have severe 
anxiety and lack of training. Such a patient has a pathological circle, when anxiety 
for their health leads to the fact that they move less and eat more, and the increasing 
weight further restricts their physical abilities. These patients often have shortness 
of breath, oedema, enlarged liver, and arterial hypertension as a possible cause of 
HF. In addition, their EF remains normal, and NT-proBNP increases slightly even 
in the presence of HF. The cause of edema in them may be a violation of venous 
outflow due to obesity, or, perhaps, taking calcium antagonists, hepatomegaly is 
caused by non-alcoholic steatohepatitis, and shortness of breath is associated with a 
large body weight and lack of training.
Outpatient patients with heart failure usually have several comorbidities. So, 
on average, there are an additional 2.5 diseases per patient with HF. It should be 
noted that anxiety and depression are frequent companions of patients with HF. 
According to our data, 22% of outpatient patients with HF have depression, and 
53% have severe anxiety.
It is necessary to distinguish between dyspnea that occurs with myocardial 
ischemia and dyspnea caused by HF, because dyspnea caused by ischemia is treated 
by restoring myocardial nutrition, and dyspnea in HF requires treatment of HF 
itself. If there are reasonable suspicions of an ischemic origin of dyspnea, then 
CT-coronary angiography should be performed.
How, then, can we distinguish HF from other causes of symptoms? To do this, 
you need to start treating the identified suspected cause of symptoms and evaluate 
the dynamics. In any case, this should be done, because if we only deal with HF 
without correcting comorbidities, we will not get a good clinical dynamic. But if 
the symptoms were associated only with extra-cardiac pathology, then we will get a 
brilliant result without the use of medications for HF.
6.  Controversies in the use of natriuretic peptides for the verification  
of HF
It is known that in HF, an increase in the level of natriuretic peptides is observed 
in the blood. They are natural antagonists of the renin-angiotensin-aldosterone 
system. This is a weapon with which the patient’s body resists the onslaught of 
neurohumoral activity in HF. However, it is very difficult to interpret the increase in 
the activity of these substances in a patient 2–3 times in comparison with the upper 
limit of the norm.
Thus, the level of brain natriuretic peptide (BNP) in obese patients is one and 
a half times lower compared to people with normal body weight despite a similar 
severity of HF [11]. In patients with liver cirrhosis, N-terminal precursor of brain 
natriuretic peptide (NT-proBNP) plasma level may increase five times in compari-
son with the control [12]. In patients with renal insufficiency, standards for the 
content of NT-proBNP have been developed depending on age [13].
The Association between NT-proBNP and the probability of developing atrial 
fibrillation [14] can be interpreted as an increase in the level of NT-proBNP in 
patients after silent paroxysms of atrial fibrillation. That is, the NT-proBNP level 
will indicate that the patient has suffered acute cardiac dysfunction, and not the 
presence of HF.
Thus, the abundance of parameters that affect the concentration of NT-proBNP 
does not allow us to make a decision about the presence or absence of HF with a small 
increase in its level. NTproBNP provided a higher negative predictive values (0.97) 
than BNP (0.87), but at lower positive predictive values (0.44 versus 0.59) [15].
Outpatient Care
6
In summary, it can be argued that the absence of an increase in NTproBNP can 
be used to exclude the diagnosis of HF, but an increase within 3 HGN should be 
interpreted very carefully.
Soluble ST2 receptor is a marker of the severity of fibrosis, remodeling, inflam-
mation, and volume load on the heart. It can claim to be a more accurate marker of 
CH dynamics in comparison with NTproBNP [16].
On the other hand, the practitioner does not need a predictor of the developing 
deterioration of the patient’s condition. The dynamics of body weight indicates an 
occurring fluid retention and the need to increase the dose of diuretics and search for 
the cause. And life-saving medications, such as renin-angiotensin-aldosterone sys-
tem blockers, should be given at targeted doses that are independent of such markers.
7. Instrumental methods for diagnosing HF
Echocardiography is most important for confirming the diagnosis of HF as a 
screening method, since if EF ≤40%, the diagnosis can be considered proven. But 
there are few such patients in outpatient practice. Thus, most outpatient patients 
have diastolic heart failure. The diastolic insufficiency is the inability of the heart to 
accept all the blood that flows to it, while there is stagnation (increased pressure) 
in front of the heart chambers. This situation can occur only with physical activity, 
and in advanced cases also at rest.
Global longitudinal strain (GLS) is a more reproducible parameter regardless 
of echocardiographic training and image quality compared to EF [17]. As GLS 
ordinarily varies with age, sex, and LV loading conditions, defining abnormal GLS 
is not uncomplicated. However, in adults, GLS <16% is abnormal, GLS >18% is 
normal, and GLS 16–18% is borderline [18].
Traditionally, diastolic insufficiency is assessed by the ratio of the velocity of 
early transmitral filling (e) and the average early velocity of diastolic movement of 
the base of the mitral valve ring (e’) [19]. It is an accurate, reliable and easily repro-
ducible method for evaluating left ventricular diastolic function. This method does 
not require a sinus rhythm. In normal persons the E/e’ ratio is <8. Values >14 have 
high specificity for increased LV filling pressures. In the range e/e’ from 8 to 14, it is 
not possible to determine definitely the presence of HF. The accuracy of the indica-
tor is reduced in severe mitral valve calcification, mitral valve defects, pericarditis 
and the presence of violations of regional contractility of the left ventricle.
Since the left atrium is also overloaded when the filling pressure of the left 
ventricle increases, it is important to detect the enlargement of the left atrium for 
the diagnosis of HF. However, it should be taken into account that the atrium can be 
expanded in athletes and with atrial fibrillation and flutter.
In symptomatic patients with normal levels of NTproBNP, no reduction in EF 
and signs of stagnation, as well as normal cardiac filling pressures at rest may have 
markedly abnormal hemodynamic responses during exercise [20]. An exercise pul-
monary artery systolic pressure ≥ 45 mm Hg identified HF with 96% sensitivity and 
95% specificity. However, such invasive tests are not acceptable for outpatient clinics.
If the etiology of HF is unclear, the need to assess the structures of the heart and 
surrounding tissues, assess the severity of fibrosis, differential diagnosis of inflam-
matory, accumulative and ischemic causes, the patient should perform cardiovas-
cular magnetic resonance (CMR) tracking with or without an assessment of late 
gadolinium enhancement (LGE). A fast long-axis strain (FLAS) at end-systole of 
12.3% and less predict the presence of HF [21]. The sensitivity and specificity of the 
method is 93% and 86%, respectively. This method is reproducible, reliable, and 
effective, but expensive.
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8. Use of acute medication tests for the diagnosis of HF
It is known that the manifestation of congestion is best reversed against the 
background of the use of diuretics, while congestion in the lungs is quickly stopped 
by nitroglycerin. However, nitroglycerin is poorly tolerated by some patients, and it 
can also be effective for spasms of any origin, including bronchial asthma. Thus, the 
specificity of reducing shortness of breath after using nitroglycerin is not great. The 
use of diuretics seems to be a more effective way to detect the relationship of low 
exercise tolerance with fluid retention in the patient’s body.
A sample with torasemide was developed for use in outpatient clinics for the dif-
ferential diagnosis of dyspnea of cardiac and non-cardiac origin with a sensitivity of 
89% and specificity of 82%.
Method of performing the test [22]. In the morning, all patients undergo a 
6-minute walking test. Then the patient should take torasemide 5 mg. 6-minute 
walking test is repeated every other day, all other things being equal. The increase in 
walking distance should be at least 15 m.
The test with torasemide is not expensive and can be performed by any medi-
cal professional without special training. The test can be used as the first stage of 
differential diagnosis in an outpatient environment in a patient with cardiovascular 
disease and dyspnea of unknown origin.
9. Complex systems for assessing the probability of having HF
The newly created H2FPEF score allows you to accurately and quickly assess the 
probability of having HF in a patient [23]. Obesity (body mass index >30 kg/m2),  
atrial fibrillation, age > 60 years, treatment with ≥2 antihypertensive drugs, 
E/e’ > 9, and pulmonary artery systolic pressure > 35 mm Hg were associated with 
HF. Atrial fibrillation gives 3 points, obesity - 2 points, other signs-1 point each. 
If the scale value is 0–1, it is very likely to exclude SN, if it is 6 or more points, it 
confirms it. Values from 2 to 5 require the use of clarifying methods (Figure 1).
The ‘HFA-PEFF diagnostic algorithm’ is also proposed [24]. In accordance with 
this algorithm, a pre-test assessment of the probability of CH is first performed. 
For this purpose, the presence of such risk factors for HF as obesity, hypertension, 
diabetes mellitus, the elderly, and atrial fibrillation is evaluated. Routine laboratory 
tests (sodium, potassium, urea, and creatinine, liver function tests, HbA1c, thyroid 
stimulating hormone, full blood count, ferritin, transferrin saturation, and hemo-
globin), electrocardiogram and echocardiography are performed. In the absence of 
an obvious extracardial cause of symptoms and the presence of risk factors for heart 
failure, even at normal levels of natriuretic peptides, HF should be suspected.
The next step is an in-depth echocardiographic study, including E/e’, left atrial 
volume index, LV mass index, relative LV wall thickness, tricuspid regurgitation 
rate, global longitudinal LV systolic strain, and serum natriuretic peptide levels if 
not already done (Table 1). If the sum of points of the HFA–PEFF Score is 1 and less 
than points, the diagnosis of CH is considered unlikely, if 5 the diagnosis of CH is 
proven. Sum 2–4 requires a transition to the next stage of diagnostics.
At Step 3 is recommended an echocardiographic or invasive hemodynamic 
exercise stress tests. The HF criteria for performing stress echocardiography are the 
average E/e ‘ratio at peak stress increases to ≥15, with or without a peak tricuspid 
regurgitation velocity of >3.4 m/s. If the above-mentioned signs are not detected 
during the exercise echocardiography, then an invasive test should have performed. 
An elevated LV filling pressures at rest (LVEDP ≥16 mmHg) or/and a high mean 




A. Functional Measurement Domain
e’ Age < 75 years:
Peak early diastolic velocity of mitral annular motion 
(cm/s)
Septal e’ < 7 or lateral e’ < 10 2
Age ≥ 75 years:
Septal e’ < 5 or lateral e’ < 7 2
E/e’ as major criterion
Peak early diastolic velocity of mitral inflow, divided by 
the mean value of e’ recorded at the septal and lateral 
mitral annulus
E/e’ ratio ≥ 15 2
Tricuspid regurgitation velocity (m/s) Peak velocity > 2.8 2
E/e’ as minor criterion E/e’ ratio 9–14 1
Global longitudinal strain (GLS) of the LV in systole (%, 
as positive value)
GLS < 16 1
B. Morphological Measurement Domain
Left atrial volume index (ml/m2) as major criterion Patient in sinus rhythm:
> 34 2
Patient in atrial fibrillation: > 40 2
Left ventricular hypertrophy (major)
LV mass index (LVMI) in g/m2 Male patient:
LV relative wall thickness (RWT) LVMI ≥149 and RWT > 0.42 2
Female patient:
Figure 1. 
The H2FPEF score with associated probability of having heart failure [23].
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In the absence of detection of these indicators, a stress test is required. An increase 
in peak exercise PCWP ≥25 mmHg is interpreted as proof of the diagnosis of HF.
Step 4 involves clarifying the cause of HF. Sometimes it is necessary to perform 
cardiac magnetic resonance imaging, computed tomography, positron emission 
tomography, myocardial biopsy, genetic and special laboratory tests.
Measurement Criterion Points
LVMI ≥122 and RWT > 0.42 2
Left atrial volume index (ml/m2) as minor criterion Patient in sinus rhythm:
29–34 1
Patient in atrial fibrillation:
34–40 1
Left ventricular hypertrophy Male patient:
Minor criteria: LVMI ≥115
LV mass index (LVMI) in g/m2 RWT > 0.42
LV relative wall thickness (RWT) LV wall thickness ≥ 12
LV wall thickness (mm) Any 1 criterion positive 1





Any 1 criterion positive 1
2 or 3 positive 1
C. Natriuretic Peptide Domain
Serum concentration of brain natriuretic peptide (BNP) 
or N-terminal proBNP (NT-proBNP) (pg/ml or ng/L)










From 0 to maximal 2 points per domain
   Select only 1 score from each domain (A, B, C) TOTAL
   Unlikely ≤1
   Intermediate 2–4
   Probable ≥5
Table 1. 
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Performing the algorithm further in step 2 is not appropriate for routine practice 
due to the need for high-level specialists and the need for invasive diagnostics, 
which increases the risk for the patient. Moreover, difficulties may arise even when 
evaluating E/e’ [25].
10. Conclusions
The diagnosis of HF in an outpatient setting is a difficult task. First, it is necessary 
to determine the clinical probability of HF by the features of manifestations, their 
dynamics, and risk factors. Then, to clarify the presence of diseases that could explain 
the symptoms, to assess the EF. In the absence of a reduction in EF ≤40%, it is required 
to calculate the HFA-PEFF Score (a more complex and expensive variant) or H2FPEF 
score (a cheaper and more available option, but less precise). If tissue Doppler imaging 
is not available, a torasemide test should be used for differential diagnosis of dyspnea.
In any case, it is impossible to allow the risk of performing a patient’s examina-
tion to exceed the benefit of the information received. The examination should be 
sufficient to make an adequate decision about the treatment of the patient, and not 
be the goal itself.
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